Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Patient Monitoring Devices Market to Grow from USD 55.60 Billion in 2026 to USD 76.11 Billion by 2031, at a CAGR of 6.4%- MarketsandMarkets™

globenewswire.com
ABT Abbott Laboratories is mentioned as a major market participant in the patient monitoring devices market, which is projected to grow. The article does not provide specific sentiment towards Abbott's performance but lists it among leading companies. DXCM Dexcom, Inc. is identified as a key player in the growing patient monitoring devices market, particularly in areas like continuous glucose monitoring. The article does not offer specific sentiment on Dexcom's individual performance. GEHC GE HealthCare is listed as a major participant in the patient monitoring devices market, which is expected to expand. The article highlights the overall market growth and competitive landscape without specific sentiment for GE HealthCare. EW Edwards Lifesciences Corporation is named as a significant company in the patient monitoring devices market. The article focuses on the market's growth and competitive dynamics, not on specific sentiment for Edwards. BAX Baxter International Inc. is mentioned as a major player in the patient monitoring devices market, which is projected to grow. The article does not provide specific sentiment towards Baxter's performance but lists it among leading companies. BSX Boston Scientific Corporation is identified as a key participant in the patient monitoring devices market. The article discusses overall market growth and trends, not specific sentiment for Boston Scientific. MASI Masimo Corporation is listed as a major company in the patient monitoring devices market, which is expected to see growth. The article focuses on market trends and competitive landscape rather than specific sentiment for Masimo.

Patient Monitoring Devices Market to Grow from USD 55.60 Billion in 2026 to USD 76.11 Billion by 2031, at a CAGR of 6.4%- MarketsandMarkets™ Delray Beach, FL, Aug. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global patient monitoring devices market will grow from USD 55.60 billion in 2026 to USD 76.11 billion by 2031, at a CAGR of 6.4% during the forecast period. Market growth is fueled by the rising prevalence of chronic diseases, increasing aging population, growing demand for continuous patient monitoring, and expanding adoption of connected healthcare technologies. Continuous advancements in wearable monitoring devices, AI-enabled analytics, remote patient monitoring platforms, wireless connectivity, and digital health ecosystems are further accelerating the adoption of patient monitoring devices across hospitals, ambulatory care centers, and home healthcare settings worldwide.

Get PDF Brochure — Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=678

Key Market Highlights

Why This Market Matters

Patient monitoring devices have become an essential component of modern healthcare by enabling continuous assessment of vital physiological parameters across hospitals, intensive care units, ambulatory care centers, and home healthcare settings. The increasing burden of cardiovascular diseases, diabetes, respiratory disorders, and hypertension is driving demand for continuous monitoring solutions that support early diagnosis, timely intervention, and improved disease management. Simultaneously, healthcare providers are increasingly adopting connected healthcare platforms, wearable technologies, remote monitoring solutions, and AI-enabled analytics to improve patient outcomes while reducing hospital readmissions and healthcare costs.

Market Overview

The patient monitoring devices market is undergoing significant transformation as healthcare systems shift from traditional bedside monitoring toward intelligent, connected, and patient-centric monitoring platforms. Digital health ecosystems integrating wearable sensors, wireless connectivity, artificial intelligence, telehealth, and cloud-based analytics are improving real-time clinical decision-making across acute care, ambulatory care, and home healthcare environments. Although alternative diagnostic approaches and increasing adoption of refurbished monitoring devices present market challenges, ongoing investments in healthcare infrastructure and digital healthcare transformation continue to support long-term market expansion.

Analyst Perspective

The patient monitoring industry is evolving beyond conventional monitoring equipment into integrated digital healthcare ecosystems. Manufacturers are increasingly focusing on compact wearable devices, software-enabled monitoring platforms, AI-driven predictive analytics, remote patient monitoring, and seamless interoperability with electronic health records. As healthcare providers continue emphasizing preventive care, personalized medicine, and home-based healthcare, companies that successfully integrate connected technologies with intelligent clinical decision support systems will strengthen their competitive advantage over the coming years.

Speak to Our Analyst — Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=678

Segment Analysis

By product, blood glucose monitoring devices account for a significant share of the patient monitoring devices market, driven by the increasing prevalence of diabetes and growing demand for continuous glucose monitoring (CGM), wearable glucose monitoring devices, and connected disease management solutions. Other major product categories include ECG devices, pulse oximeters, blood pressure monitors, fetal & neonatal monitors, EEG systems, spirometers, and implantable loop recorders (ILRs).

By end user, hospitals and clinics accounted for the largest market share owing to increasing patient admissions, rising prevalence of chronic diseases, and growing demand for continuous monitoring in emergency, critical care, and intensive care settings. Increasing investments in connected monitoring platforms and integrated healthcare technologies are further supporting segment growth.

Regional Analysis

Rapid improvements in healthcare infrastructure across Asia Pacific, Latin America, and the Middle East & Africa are creating significant growth opportunities for patient monitoring device manufacturers. Increasing government investments in hospitals, specialty care centers, digital healthcare programs, and health insurance coverage are improving access to advanced monitoring technologies. The growing adoption of connected healthcare, wearable devices, and remote patient monitoring solutions across emerging markets is expected to support sustained market expansion over the forecast period.

Key Industry Trends

Competitive Landscape

The patient monitoring devices market is highly competitive, with leading companies collectively accounting for approximately 70–72% of the global market in 2026. Major market participants include Medtronic Plc. (Ireland), Abbott Laboratories (US), Dexcom, Inc. (US), GE HealthCare (US), Philips Healthcare (Netherlands), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), Edwards Lifesciences Corporation (US), Getinge AB (Sweden), Baxter International Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Boston Scientific Corporation (US), Masimo Corporation (US), Omron Corporation (Japan), ARCHIMED SAS (Natus Medical) (France), Compumedics Limited (Australia), and Nonin Medical, Inc. (US). Companies continue investing in wearable technologies, connected monitoring platforms, AI-enabled analytics, and cloud-integrated healthcare solutions to strengthen their competitive positions.

Related Reports

Wearable Healthcare Devices Market

IoT Medical Devices Market